Milrinone in Congenital Diaphragmatic Hernia

NCT02951130 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

66

Enrollment

NETWORK

Sponsor class

Conditions

Congenital Diaphragmatic Hernia
Persistent Pulmonary Hypertension of the Newborn
Hypoxemic Respiratory Failure
Pulmonary Hypoplasia

Interventions

DRUG: Milrinone
DRUG: Placebo (5% Dextrose)

Sponsor

NICHD Neonatal Research Network

Collaborators

[object Object]